Published in Res Pharm Sci on December 01, 2016
Mutations of the BRAF gene in human cancer. Nature (2002) 65.42
LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. Protein Eng (1995) 19.22
RAS oncogenes: the first 30 years. Nat Rev Cancer (2003) 8.61
Docking and scoring in virtual screening for drug discovery: methods and applications. Nat Rev Drug Discov (2004) 8.10
The Raf/MEK/ERK pathway: new concepts of activation. Biol Cell (2001) 3.08
BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing. J Med Genet (2004) 2.75
Isotype-specific functions of Raf kinases. Exp Cell Res (1999) 1.79
Critical assessment of QSAR models of environmental toxicity against Tetrahymena pyriformis: focusing on applicability domain and overfitting by variable selection. J Chem Inf Model (2008) 1.79
Targeting the mitogen-activated protein kinase pathway: physiological feedback and drug response. Clin Cancer Res (2010) 1.77
Raf kinases: function, regulation and role in human cancer. Biochim Biophys Acta (2007) 1.64
Ligand docking and structure-based virtual screening in drug discovery. Curr Top Med Chem (2007) 1.53
Current management and novel agents for malignant melanoma. J Hematol Oncol (2012) 1.53
RAF protein-serine/threonine kinases: structure and regulation. Biochem Biophys Res Commun (2010) 1.37
Recent developments in anti-cancer agents targeting the Ras/Raf/ MEK/ERK pathway. Recent Pat Anticancer Drug Discov (2009) 1.35
Targeting insulin-like growth factor axis in hepatocellular carcinoma. J Hematol Oncol (2011) 1.22
A pooled analysis of sequential therapies with sorafenib and sunitinib in metastatic renal cell carcinoma. Oncology (2012) 0.98
Comparative QSAR: Toward a Deeper Understanding of Chemicobiological Interactions. Chem Rev (1996) 0.98
Sensitive detection of BRAF V600E mutation by Amplification Refractory Mutation System (ARMS)-PCR. Biomark Res (2013) 0.98
Novel potent BRAF inhibitors: toward 1 nM compounds through optimization of the central phenyl ring. J Med Chem (2009) 0.92
B-Raf mutation: a key player in molecular biology of cancer. Exp Mol Pathol (2013) 0.91
Computer-aided drug discovery and development. Methods Mol Biol (2011) 0.88
Virtual screening for Raf-1 kinase inhibitors based on pharmacophore model of substituted ureas. Eur J Med Chem (2008) 0.82
Computational methods for the identification and optimisation of high quality leads. Comb Chem High Throughput Screen (2004) 0.78
Synthesis and evaluation of antimicrobial activity of cyclic imides derived from phthalic and succinic anhydrides. Res Pharm Sci (2017) 0.75
Biological evaluation, docking and molecular dynamic simulation of some novel diaryl urea derivatives bearing quinoxalindione moiety. Res Pharm Sci (2017) 0.75